MYC and neoplasm: Treatment of tumors for 4 consecutive days with the PCTK1 inhibitor (10 μM) significantly impaired tumor growth in c-Myc overexpressing tumors, when compared to control (DMSO treatment) (V<0) (Fig. 7A,B).